Preclinical evaluation of the Pht proteins as potential cross-protective pneumococcal vaccine antigens

Infection and Immunity

Volumn 79, Issue 1, 2011, Pages 238-245

  Godfroid, Fabrice ^a   Hermand, Philippe ^a   Verlant, Vincent ^a   Denoël, Philippe ^a   Poolman, Jan T ^a  

^a GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; PNEUMOCOCCUS VACCINE; PROTEIN CBPA; PROTEIN PHTA; PROTEIN PHTB; PROTEIN PHTD; PROTEIN PHTE; PROTEIN PSAA; PROTEIN PSPA; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; DRUG EFFICACY; FEMALE; HUMORAL IMMUNITY; IMMUNIZATION; MOUSE; NONHUMAN; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; DRUG EVALUATION, PRECLINICAL; FEMALE; IMMUNIZATION, PASSIVE; MICE; MICE, INBRED STRAINS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES;

EID: 78650919043     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00378-10     Document Type: Article

References (53)

1. Adamou, J. E., J. H. Heinrichs, A. L. Erwin, W. Walsh, T. Gayle, M. Dor-mitzer, R. Dagan, Y. A. Brewah, P. Barren, R. Lathigra, S. Langermann, S. Koenig, and S. Johnson. 2001. Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis. Infect. Immun. 69:949-958.
2. Alexander, J. E., R. A. Lock, C. C. A. M. Peeters, J. T. Poolman, P. W. Andrew, T. J. Mitchell, D. Hansman, and J. C. Paton. 1994. Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae. Infect. Immun. 62:5683-5688.
3. Beghetto, E., N. Gargano, S. Ricci, G. Garufi, S. Peppoloni, F. Montagnani, M. Oggioni, G. Pozzi, and F. Felici. 2006. Discovery of novel Streptococcus pneumoniae antigens by screening a whole-genome X-display library. FEMS Microbiol. Lett. 262:14-21.
4. Berry, A. M., and J. C. Paton. 1996. Sequence heterogeneity of PsaA, a 37-kilodalton putative adhesin essential for virulence of Streptococcus pneumoniae. Infect. Immun. 64:5255-5262.
5. Briles, D. E., S. K. Hollingshead, J. King, A. Swift, P. A. Braun, M. K. Park, L. M. Ferguson, M. H. Nahm, and G. S. Nabors. 2000. Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA. J. Infect. Dis. 182:1694-1701.
6. Briles, D. E., S. K. Hollingshead, J. C. Paton, E. W. Ades, L. Novak, F. W. van Ginkel, and W. H. Benjamin, Jr. 2003. Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae. J. Infect. Dis. 188:339-348.
7. Brooks-Walter, A., D. E. Briles, and S. K. Hollingshead. 1999. The pspC gene of Streptococcus pneumoniae encodes a polymorphic protein, PspC, which elicits cross-reactive antibodies to PspA and provides immunity to pneumococcal bacteremia. Infect. Immun. 67:6533-6542.
8. Brown, J. S., A. D. Ogunniyi, M. C. Woodrow, D. W. Holden, and J. C. Paton. 2001. Immunization with components of two iron uptake ABC transporters protects mice against systemic Streptococcus pneumoniae infection. Infect. Immun. 69:6702-6706.
9. Bunker, V. W., L. J. Hinks, M. S. Lawson, and B. E. Clayton. 1984. Assessment of zinc and copper status of healthy elderly people using metabolic balance studies and measurement of leucocyte concentrations. Am. J. Clin. Nutr. 40:1096-1102.
10. Crain, M. J., W. D. Waltman II, J. S. Turner, J. Yother, D. F. Talkington, L. S. McDaniel, B. M. Gray, and D. E. Briles. 1990. Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae. Infect. Immun. 58:3293-3299.
11. Dagan, R., D. Engelhard, E. Piccard, and D. Englehard. 1992. Epidemiology of invasive childhood pneumococcal infections in Israel. The Israeli Pediatric Bacteremia and Meningitis Group. JAMA 268:3328-3332.
12. Dagan, R., H. Kayhty, T. Wuorimaa, M. Yaich, F. Bailleux, O. Zamir, and J. Eskola. 2004. Tolerability and immunogenicity of an eleven valent mixed carrier Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid or tetanus protein conjugate vaccine in Finnish and Israeli infants. Pediatr. Infect. Dis. J. 23:91-98.
13. Darrieux, M., E. N. Miyaji, D. M. Ferreira, L. M. Lopes, A. P. Y. Lopes, B. Ren, D. E. Briles, S. K. Hollingshead, and L. C. C. Leite. 2007. Fusion proteins containing family 1 and family 2 PspA fragments elicit protection against Streptococcus pneumoniae that correlates with antibody-mediated enhancement of complement deposition. Infect. Immun. 75:5930-5938.
14. Darrieux, M., A. T. Moreno, D. M. Ferreira, F. C. Pimenta, A. L. S. S. de Andrade, A. P. Y. Lopes, L. C. C. Leite, and E. N. Miyaji. 2008. Recognition of pneumococcal isolates by antisera raised against PspA fragments from different clades. J. Med. Microbiol. 57:273-278.
15. Dintilhac, A., G. Alloing, C. Granadel, and J.-P. Claverys. 1997. Competence and virulence of Streptococcus pneumoniae: Adc and PsaA mutants exhibit a requirement for Zn and Mn resulting from inactivation of putative ABC metal permeases. Mol. Microbiol. 25:727-739.
16. Fedson, D. C., and D. M. Musher. 2004. Pneumococcal polysaccharide vaccines, p. 529-588. In S. A. Plotkin and W. A. Orenstein (ed.), Vaccines, 4th ed. Elsevier, Inc., Philadelphia, PA.
17. Ferreira, D. M., A. P. M. Ar̂eas, M. Darrieux, L. C. C. Leite, and E. N. Miyaji. 2006. DNA vaccines based on genetically detoxified derivatives of pneumolysin fail to protect mice against challenge with Streptococcus pneu-moniae. FEMS Immunol. Med. Microbiol. 46:291-297.
18. Gaŗcon, N., P. Chomez, and M. Van Mechelen. 2007. GlaxoSmithKline adjuvant systems in vaccines: concepts, achievements and perspectives. Expert Rev. Vaccines 6:723-739.
19. Giefing, C., A. L. Meinke, M. Hanner, T. Henics, D. B. Minh, D. Gelbmann, U. Lundberg, B. M. Senn, M. Schunn, A. Habel, B. Henriques-Normark, Å. Örtqvist, M. Kalin, A. von Gabain, and E. Nagy. 2008. Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies. J. Exp. Med. 205: 117-131.
20. Glover, D. T., S. K. Hollingshead, and D. E. Briles. 2008. Streptococcus pneumoniae surface protein PcpA elicits protection against lung infection and fatal sepsis. Infect. Immun. 76:2767-2776.
21. Hamel, J., N. Charland, I. Pineau, C. Ouellet, S. Rioux, D. Martin, and B. R. Brodeur. 2004. Prevention of pneumococcal disease in mice immunized with conserved surface-accessible proteins. Infect. Immun. 72:2659-2670.
22. Harlyk, C., J. Mccourt, G. Bordin, A. R. Rodriguez, and A. van der Eeckhout. 1997. Determination of copper, zinc and iron in broncho-alveolar lavages by atomic absorption spectroscopy. J. Trace Elem. Med. Biol. 11:137-142.
23. Hausdorff, W. P., D. R. Feikin, and K. P. Klugman. 2005. Epidemiological differences among pneumococcal serotypes. Lancet Infect. Dis. 5:83-93.
24. Hava, D. L., and A. Camilli. 2002. Large-scale identification of serotype 4 Streptococcus pneumoniae virulence factors. Mol. Microbiol. 45:1389-1405.
25. Hollingshead, S. K., R. Becker, and D. E. Briles. 2000. Diversity of PspA: mosaic genes and evidence for past recombination in Streptococcus pneu-moniae. Infect. Immun. 68:5889-5900.
26. Holmlund, E., B. Simell, T. Jaakkola, M. Lahdenkari, J. Hamel, B. Brodeur, T. Kilpi, and H. Käyhty. 2007. Serum antibodies to the pneumococcal surface proteins PhtB and PhtE in Finnish infants and adults. Pediatr. Infect. Dis. J. 26:447-449.
27. Hostetter, M. K. 1999. Opsonic and nonopsonic interactions of C3 with Streptococcus pneumoniae. Microb. Drug Resist. 5:85-89.
28. Janulczyk, R., F. Iannelli, A. G. Sjöholm, G. Pozzi, and L. Björck. 2000. Hic, a novel surface protein of Streptococcus pneumoniae that interferes with complement function. J. Biol. Chem. 275:37257-37263.
29. Lipsitch, M. 1997. Vaccination against colonizing bacteria with multiple serotypes. Proc. Natl. Acad. Sci. U.S.A. 94:6571-6576.
30. Luo, R., B. Mann, W. S. Lewis, A. Rowe, R. Heath, M. L. Stewart, A. E. Hamburger, S. Sivakolundu, E. R. Lacy, P. J. Bjorkman, E. Tuomanen, and R. W. Kriwacki. 2005. Solution structure of choline binding protein A, the major adhesin of Streptococcus pneumoniae. EMBO J. 24:34-43.
31. Malley, R. 2010. Antibody and cell-mediated immunity to Streptococcus pneumoniae: implications for vaccine development. J. Mol. Med. 88:135-142.
32. Maruvada, R., N. V. Prasadarao, and C. E. Rubens. 2009. Acquisition of factor H by a novel surface protein on group B Streptococcus promotes complement degradation. FASEB J. 23:3967-3977.
33. Mbelle, N., R. E. Huebner, A. D. Wasas, A. Kimura, I. Chang, and K. P. Klugman. 1999. Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J. Infect. Dis. 180:1171-1176. (Pubitemid 30070201)
34. McCullers, J. A., and E. I. Tuomanen. 2001. Molecular pathogenesis of pneumococcal pneumonia. Front Biosci. 6:D877-D889.
35. Melin, M., E. Di Paolo, L. Tikkanen, H. Jarva, C. Neyt, H. Käyhty, S. Meri, J. Poolman, and M. Väkeväinen. 2010. Interaction of pneumococcal histidine triad proteins with human complement. Infect. Immun. 78:2089-2098.
36. Miyaji, E. N., D. M. Ferreira, A. P. Y. Lopes, M. C. C. Brandileone, W. O. Dias, and L. C. C. Leite. 2002. Analysis of serum cross-reactivity and cross-protection elicited by immunization with DNA vaccines against Streptococcus pneumoniae expressing PspA fragments from different clades. Infect. Im-mun. 70:5086-5090.
37. Morsczeck, C., T. Prokhorova, J. Sigh, M. Pfeiffer, M. Bille-Nielsen, J. Petersen, A. Boysen, T. Kofoed, N. Frimodt-Møller, P. Nyborg-Nielsen, and P. Schrotz-King. 2008. Streptococcus pneumoniae: proteomics of surface proteins for vaccine development. Clin. Microbiol. Infect. 14:74-81.
38. Nabors, G. S., P. A. Braun, D. J. Herrmann, M. L. Heise, D. J. Pyle, S. Gravenstein, M. Schilling, L. M. Ferguson, S. K. Hollingshead, D. E. Briles, and R. S. Becker. 2000. Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules. Vaccine 18:1743-1754.
39. Nunes, S., R. Sa-Leao, L. C. Pereira, and H. de Lencastre. 2008. Emergence of a serotype 1 Streptococcus pneumoniae lineage colonising healthy children in Portugal in the seven-valent conjugate vaccination era. Clin. Microbiol. Infect. 14:82-84.
40. Ogunniyi, A. D., R. L. Folland, D. E. Briles, S. K. Hollingshead, and J. C. Paton. 2000. Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae. Infect. Immun. 68:3028-3033.
41. Ogunniyi, A. D., M. Grabowicz, D. E. Briles, J. Cook, and J. C. Paton. 2007. Development of a vaccine against invasive pneumococcal disease based on combinations of virulence proteins of Streptococcus pneumoniae. Infect. Immun. 75:350-357.
42. 2+-dependent repressor AdcR and inhibit complement deposition through the recruitment of complement factor H. FASEB J. 23:731-738.
43. Panina, E. M., A. A. Mironov, and M. S. Gelfand. 2003. Comparative genomics of bacterial zinc regulons: enhanced ion transport, pathogenesis, and rearrangement of ribosomal proteins. Proc. Natl. Acad. Sci. U.S.A. 100: 9912-9917.
44. Paton, J. C, R. A. Lock, C.-J. Lee, J. P. Li, A. M. Berry, T. J. Mitchell, P. W. Andrew, D. Hansman, and G. J. Boulnois. 1991. Purification and immuno-genicity of genetically obtained pneumolysin toxoids and their conjugation to Streptococcus pneumoniae type 19F polysaccharide. Infect. Immun. 59:2297-2304.
45. Riboldi-Tunnicliffe, A., N. W. Isaacs, and T. J. Mitchell. 2005. 1.2 Å crystal structure of the S. pneumoniae PhtA histidine triad domain a novel zinc binding fold. FEBS Lett. 579:5353-5360.
46. Rioux, S., C. Neyt, E. Di Paolo, L. Turpin, N. Charland, S. Labb́e, M.-C. Mortier, T. J. Mitchell, C. Feron, D. Martin, and J. T. Poolman. Transcrip-tional regulation, occurrence and putative role of the Pht family of Streptococcus pneumoniae. Microbiology, in press.
47. Silva, M., J. Cabrera-Crespo, M. E. Sbrogio-Almeida, E. N. Miyaji, P. L. Ho, L. C. C. Leite, and A. P. Y. Lopes. 2007. Optimizing expression of Streptococcus pneumoniae surface protein A, PspA: serocross-reactivity within families of antisera induced against clades 1 and 3. Mol. Biotechnol. 37:146-154.
48. Singleton, R. J., T. W. Hennessy, L. R. Bulkow, L. L. Hammitt, T. Zulz, D. A. Hurlburt, J. C. Butler, K. Rudolph, and A. Parkinson. 2007. Invasive pneu-mococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 297:1784-1792.
49. Smart, L. E., A. J. Dougall, and R. W. A. Girdwood. 1987. New 23-valent pneumococcal vaccine in relation to pneumococcal serotypes in systemic and non-systemic disease. J. Infect. 14:209-215.
50. Whalan, R. H., S. G. P. Funnell, L. D. Bowler, M. J. Hudson, A. Robinson, and C. G. Dowson. 2006. Distribution and genetic diversity of the ABC transporter lipoproteins PiuA and PiaA within Streptococcus pneumoniae and related streptococci. J. Bacteriol. 188:1031-1038.
51. Wizemann, T. M., J. H. Heinrichs, J. E. Adamou, A. L. Erwin, C. Kunsch, G. H. Choi, S. C. Barash, C. A. Rosen, H. R. Masure, E. Tuomanen, A. Gayle, Y. A. Brewah, W. Walsh, P. Barren, R. Lathigra, M. Hanson, S. Langer-mann, S. Johnson, and S. Koenig. 2001. Use of a whole-genome approach to identify vaccine molecules affording protection against Streptococcus pneu-moniae infection. Infect. Immun. 69:1593-1598.
52. Wu, K., X. Zhang, J. Shi, N. Li, D. Li, M. Luo, J. Cao, N. Yin, H. Wang, W. Xu, Y. He, and Y. Yin. 2010. Immunization with a combination of three pneumococcal proteins confers additive and broad protection against Streptococcus pneumoniae infections in mice. Infect. Immun. 78:1276-1283.
53. Zhang, Y., A. W. Masi, V. Barniak, K. Mountzouros, M. K. Hostetter, and B. A. Green. 2001. Recombinant PhpA protein, a unique histidine motif-containing protein from Streptococcus pneumoniae, protects mice against intranasal pneumococcal challenge. Infect. Immun. 69:3827-3836.